Balfe P - Search Results

1

Circadian control of hepatitis B virus replication.

Zhuang X, Forde D, Tsukuda S, D'Arienzo V, Mailly L, Harris JM, Wing PAC, Borrmann H, Schilling M, Magri A, Rubio CO, Maidstone RJ, Iqbal M, Garzon M, Minisini R, Pirisi M, Butterworth S, Balfe P, Ray DW, Watashi K, Baumert TF, McKeating JA. Zhuang X, et al. Among authors: balfe p. Nat Commun. 2021 Mar 12;12(1):1658. doi: 10.1038/s41467-021-21821-0. Nat Commun. 2021. PMID: 33712578 Free PMC article.

2

Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type I gp120.

McKeating JA, Cordell J, Dean CJ, Balfe P. McKeating JA, et al. Among authors: balfe p. Virology. 1992 Dec;191(2):732-42. doi: 10.1016/0042-6822(92)90249-o. Virology. 1992. PMID: 1280382

3

Development of a neutralizing antibody response during acute primary human immunodeficiency virus type 1 infection and the emergence of antigenic variants.

Lewis J, Balfe P, Arnold C, Kaye S, Tedder RS, McKeating JA. Lewis J, et al. Among authors: balfe p. J Virol. 1998 Nov;72(11):8943-51. doi: 10.1128/JVI.72.11.8943-8951.1998. J Virol. 1998. PMID: 9765439 Free PMC article.

4

The role of the viral glycoprotein in HIV-1 persistence.

McKeating JA, Balfe P. McKeating JA, et al. Among authors: balfe p. Immunol Lett. 1999 Jan;65(1-2):63-70. doi: 10.1016/s0165-2478(98)00126-6. Immunol Lett. 1999. PMID: 10065629 Review.

5

Truncated gp120 envelope glycoprotein of human immunodeficiency virus 1 elicits a broadly reactive neutralizing immune response.

Jeffs SA, Shotton C, Balfe P, McKeating JA. Jeffs SA, et al. Among authors: balfe p. J Gen Virol. 2002 Nov;83(Pt 11):2723-2732. doi: 10.1099/0022-1317-83-11-2723. J Gen Virol. 2002. PMID: 12388808

6

Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner.

McKeating JA, Zhang LQ, Logvinoff C, Flint M, Zhang J, Yu J, Butera D, Ho DD, Dustin LB, Rice CM, Balfe P. McKeating JA, et al. Among authors: balfe p. J Virol. 2004 Aug;78(16):8496-505. doi: 10.1128/JVI.78.16.8496-8505.2004. J Virol. 2004. PMID: 15280458 Free PMC article.

7

Diverse CD81 proteins support hepatitis C virus infection.

Flint M, von Hahn T, Zhang J, Farquhar M, Jones CT, Balfe P, Rice CM, McKeating JA. Flint M, et al. Among authors: balfe p. J Virol. 2006 Nov;80(22):11331-42. doi: 10.1128/JVI.00104-06. Epub 2006 Aug 30. J Virol. 2006. PMID: 16943299 Free PMC article.

8

Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity.

Grove J, Huby T, Stamataki Z, Vanwolleghem T, Meuleman P, Farquhar M, Schwarz A, Moreau M, Owen JS, Leroux-Roels G, Balfe P, McKeating JA. Grove J, et al. Among authors: balfe p. J Virol. 2007 Apr;81(7):3162-9. doi: 10.1128/JVI.02356-06. Epub 2007 Jan 10. J Virol. 2007. PMID: 17215280 Free PMC article.

9

Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo.

von Hahn T, Yoon JC, Alter H, Rice CM, Rehermann B, Balfe P, McKeating JA. von Hahn T, et al. Among authors: balfe p. Gastroenterology. 2007 Feb;132(2):667-78. doi: 10.1053/j.gastro.2006.12.008. Epub 2006 Dec 3. Gastroenterology. 2007. PMID: 17258731

10

Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies.

Stamataki Z, Coates S, Evans MJ, Wininger M, Crawford K, Dong C, Fong YL, Chien D, Abrignani S, Balfe P, Rice CM, McKeating JA, Houghton M. Stamataki Z, et al. Among authors: balfe p. Vaccine. 2007 Nov 7;25(45):7773-84. doi: 10.1016/j.vaccine.2007.08.053. Epub 2007 Sep 14. Vaccine. 2007. PMID: 17919789

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters